$16.96 -0.06 (-0.35%)
11/6/2009 4:01 PM

Pfizer, Inc. (PFE)

CAPS Rating: 4 out of 5

A research-based, pharmaceutical Company which discovers, develops, manufactures and markets prescription medicines for humans and animals.

Results 1 - 20 of 940 1 2 3 4 5 6 7 8 9 10 Next »

Recs

0
Member Avatar WPThatcher (69.32) Submitted: 10/31/2009 3:36:38 PM : Outperform Start Price: $16.74 PFE Score: -1.96

Well-run and cash-rich.. Demographics favor this company.

Recs

0
Member Avatar romaray (< 20) Submitted: 10/22/2009 2:02:37 PM : Underperform Start Price: $17.26 PFE Score: +0.16

Changes in reimbursement as health care costs are rationalized.

Recs

0
Member Avatar stuinkc (50.50) Submitted: 10/22/2009 9:44:11 AM : Outperform Start Price: $17.29 PFE Score: -1.37

value, dividend

Recs

0
Member Avatar Rheddrian (< 20) Submitted: 10/21/2009 3:42:12 PM : Outperform Start Price: $17.45 PFE Score: -1.50

Cake Dex test run

Recs

0
Member Avatar vshar (37.85) Submitted: 10/21/2009 2:47:38 PM : Outperform Start Price: $17.51 PFE Score: -0.72

After healthcare reforms the pimps will be gone and the benefit will go to the patients and indirectly to the pharmacuticals

Recs

0
Member Avatar Nostradamuss (45.85) Submitted: 10/20/2009 9:03:58 AM : Outperform Start Price: $18.11 PFE Score: -3.78

++

Recs

0
Member Avatar germanjuggler (< 20) Submitted: 10/20/2009 5:15:31 AM : Outperform Start Price: $18.11 PFE Score: -3.78

it is viagra for the S&P500

Recs

0
Member Avatar siri22 (23.03) Submitted: 10/19/2009 3:04:47 PM : Outperform Start Price: $17.87 PFE Score: -2.50

good company, meds for boomers, always chance for block buster drug

Recs

0
Member Avatar FrankieB213 (< 20) Submitted: 10/15/2009 1:56:11 PM : Outperform Start Price: $17.25 PFE Score: +0.30

I actually bought this stock under $16.50 months ago and have been waiting for this acquisition to take place. Right now everything is in place for this stock to break the $20 range by end of year. Plus they have a solid dividend that is not going anywhere anytime soon

Recs

0
Member Avatar fjm1502 (36.23) Submitted: 10/12/2009 5:52:22 PM : Outperform Start Price: $16.73 PFE Score: +1.61

Awesome company with 15 plus pending FDA approval for drugs.

Recs

0
Member Avatar joker11b (54.82) Submitted: 10/7/2009 9:23:51 AM : Outperform Start Price: $16.58 PFE Score: +0.50

Flu epidemic. Current proposal to FDA over HIV medicine.

Recs

0
Member Avatar SequoiaStocks (28.26) Submitted: 9/18/2009 10:22:05 AM : Outperform Start Price: $16.46 PFE Score: +2.50

This account tracks the performance of the investment firm Ruane, Cunniff, and Goldfarb - the investment manager of Sequoia Fund.

Recs

0
Member Avatar hirooshivam (< 20) Submitted: 9/8/2009 4:59:02 PM : Outperform Start Price: $16.11 PFE Score: +0.91

global name known for decades and their research will get this stock ahead of their competitors

Recs

0
Member Avatar DanteSparda (81.87) Submitted: 9/3/2009 7:57:49 PM : Outperform Start Price: $15.85 PFE Score: +0.27

Can't say I'm too thrilled with the prospect of a $2.3 billion fine for shady quid pro quo business practices. But nevertheless people need drugs and Pfizer has the line up. Hopefully, the drug pipeline from Wyeth will make up for expiring patents from Lipitor in 2011. Let's just hope they don't try to market the next Thalidomide or something.

Recs

0
Member Avatar HarukanaruAo (72.96) Submitted: 8/27/2009 2:45:16 AM : Outperform Start Price: $16.30 PFE Score: -3.46

The Wyeth acquisition will probably weigh down the stocks for a while, but gaining that pipeline of potential drugs and product should pay off in a couple of years. The management also seems to be devoted to streamlining research and development and to focusing on high-potential projects.

Recs

0
Member Avatar zsanabri (< 20) Submitted: 8/26/2009 6:49:10 PM : Outperform Start Price: $16.49 PFE Score: -1.59

worked for the company for 28 years

Recs

0
Member Avatar charlesumeugokwe (< 20) Submitted: 8/25/2009 2:34:42 PM : Outperform Start Price: $16.62 PFE Score: -2.41

astounding balance sheet

Recs

0
Member Avatar cashandgrab (60.74) Submitted: 8/24/2009 6:31:29 PM : Outperform Start Price: $16.59 PFE Score: -1.95

Drug companies manufacture money in the form of little pills. The population is getting older and needs more pills to keep going, ergo: more money for Pfizer.

Recs

0
Member Avatar Prodders (< 20) Submitted: 8/17/2009 3:35:10 PM : Outperform Start Price: $15.77 PFE Score: -1.68

Low P/E, solid company, getting very little value placed on the current pipeline. Looks reasonable timing on a technical basis too, having recently broken above the 200 day mva.

Recs

0
Member Avatar FDinvestments (< 20) Submitted: 8/17/2009 11:49:35 AM : Outperform Start Price: $15.75 PFE Score: -1.55

good fundamentals

Featured Broker Partners